Proactive Investors - Run By Investors For Investors

Holista CollTech secures distribution rights for unique algae supplement

The stem-cell growth promoting algae is harvested from Klamath Lake in Oregon.
an old couple
The supplement has anti-aging properties

Holista CollTech Limited (ASX:HCT) has secured the global distribution rights for a supplement, sourced from algae found in pristine conditions in a lake in the U.S., that can enhance stem cell growth.

The Aphanizomenon Flos-aquae (AFA) algae is harvested from Klamath Lake in Oregon, which is considered to be the most pristine environment in North America after Alaska.

When consumed, the Klamax™ algae supplement is believed to enhance general wellness and anti-aging health, by promoting and supporting a normal neurological, somatic and stem-cells physiology.

The algae’s unusual properties are due in part to the fact that it grows on the surface of the lake that sits on top of a 7,700-year bed of rich volcanic ash.

Developed by scientist Dr Stefano Scoglio, the product has a high concentration of a molecule endowed with neuromodulating, immune-enhancing and neuronal stem-cell promoting activities.

Holista intends to develop oral and transdermal preparations to be sold through network marketing platform, iGalen International Inc.

In September 2017, Holista announced that it was acquiring a 47% stake in iGalen from Dr Rajen Manicka for a nominal consideration of US$1 pending shareholder approval.

iGalen has more than 12,500 distributors worldwide, and intends to enter Australia and New Zealand, in addition to the U.S., Canada, Malaysia, Singapore and Philippines.

In August 2017, Holista had secured the global rights for Emulin®, an all-natural carbohydrates manager developed by two Nobel Prize nominees.

View full HCT profile View Profile

Holista Colltech Ltd Timeline

Newswire
September 19 2017

Related Articles

CBD oil
November 16 2018
The company’s technology creates nano-scale emulsion mixtures that allow fluids to mix that normally don’t mix, such as CBD oil and water
Nemaura Medical Inc CEO Dr Faz Chowdhury
November 06 2018
The medtech company is eying explosive growth with sugarBEAT, on the cusp of launching in the UK, followed by the rest of Europe in 2018
myLotus testing kit
October 31 2018
The launch at the Fertility Show in London at the start of November is the first step in a switch in focus brought about by new executive chairman Matthew Walls

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use